Behçet’s Disease with Extremely High Levels of Urinary β2-Microglobulin after Non-Steroidal Anti-Inflammatory Drug Treatment
-
Published:2021
Issue:4
Volume:254
Page:283-286
-
ISSN:0040-8727
-
Container-title:The Tohoku Journal of Experimental Medicine
-
language:en
-
Short-container-title:Tohoku J. Exp. Med.
Author:
Ogino Ryohei1, Shimada Karin1, Narai Daiki1, Goto Masanori1, Sato Katsuhiro1, Katsuta Yoshihisa1, Shiigi Akimasa1, Ueda Juri1, Oyama Chika1, Fujikawa Yuko1, Miyazawa Isabelle1, Ohara Takahiro1, Sumitomo Kazuhiro1, Sato Shigeru1, Koinuma Nobuo1, Kanno Atsuhiro1, Furukawa Katsutoshi1
Affiliation:
1. Division of Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University,
Publisher
Tohoku University Medical Press
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference11 articles.
1. Adams, D.H., Howie, A.J., Michael, J., McConkey, B., Bacon, P.A. & Adu, D.(1986) Non-steroidal anti-inflammatory drugs and renal failure. Lancet, 1, 57-60. 2. Adil, A., Goyal, A., Bansal, P. & Quint, J.M.(2021) Behçet’s disease. In StatPearls, StatPearls Publishing, Treasure Island, FL, USA. 3. Akpolat, T., Akkoyunlu, M., Akpolat, I., Dilek, M., Odabas, A.R. & Ozen, S.(2002) Renal Behcet’s disease: a cumulative analysis. Semin. Arthritis Rheum., 31, 317-337. 4. Argyropoulos, C.P., Chen, S.S., Ng, Y,H., Roumelioti, M.E., Shaffi, K., Singh, P.P. & Tzamaloukas, A.H.(2017) Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front. Med. (Lausanne), 4, 73. 5. Leonard, D., Cortese, C., Wadei, H.M., Porter Ii, I.E. & Aslam, N.(2018) Behcet’s syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - successful treatment with etanercept. Clin. Nephrol., 89, 371-375.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|